These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of stroke in patients with atrial fibrillation. Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692 [No Abstract] [Full Text] [Related]
3. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention]. Neundörfer B Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771 [No Abstract] [Full Text] [Related]
5. Using anticoagulation or aspirin to prevent stroke. Aspirin is the logical choice for non-rheumatic atrial fibrillation. Taylor FC; Ebrahim S BMJ; 2000 Apr; 320(7240):1010. PubMed ID: 10809558 [No Abstract] [Full Text] [Related]
6. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. Hu D; Sun Y J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352 [No Abstract] [Full Text] [Related]
7. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ; J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454 [TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment in atrial fibrillation. Lip GY; Boos CJ Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation. Benavente O; Hart RG J Neurol Sci; 1997 Dec; 153(1):110; author reply 112. PubMed ID: 9455988 [No Abstract] [Full Text] [Related]
10. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
11. Atrial fibrillation and stroke risk prevention in real-life clinical practice. Tay KH; Lip GY; Lane DA Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398 [No Abstract] [Full Text] [Related]
12. Stroke prevention in atrial fibrillation--pharmacologic strategies. Tiyyagura SR; Goldbarg SH; Mehta D Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935 [TBL] [Abstract][Full Text] [Related]
14. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative]. Själander A; Wallentin L; Rosenqvist M; Svensson P Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862 [No Abstract] [Full Text] [Related]
15. Reducing the risk for stroke in patients who have atrial fibrillation. Garcia DA; Hylek E Cardiol Clin; 2008 May; 26(2):267-75, vii. PubMed ID: 18406999 [TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulant therapy for patients with atrial fibrillation--an update. Hylek EM Thromb Res; 2008; 123 Suppl 1():S46-9. PubMed ID: 18809205 [No Abstract] [Full Text] [Related]
17. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulants vs. antiplatelet therapy. Hitzeman N; Applebaum S Am Fam Physician; 2008 May; 77(9):1250-2. PubMed ID: 18540488 [No Abstract] [Full Text] [Related]
19. Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy? Okumura Y J Cardiovasc Electrophysiol; 2009 Sep; 20(9):994-6. PubMed ID: 19549032 [No Abstract] [Full Text] [Related]
20. Usefulness of antiplatelet drugs in ischaemic stroke prevention--update on new trials. Rother J Cerebrovasc Dis; 2007; 24 Suppl 1():112-5. PubMed ID: 17971646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]